IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
ANG Lifesciences India IPO is a Fixed Price listing on BSE SME exchange, with an ipo size of ₹ 12.01 Cr. The company is based in Amritsar and caters to Pharmaceutical sector. Guiness Corporate Advisors is the merchant banker of ANG Lifesciences India IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 16th August 2017.
ANG Lifesciences India IPO posted revenues of ₹ 67.66 Cr. and PAT of ₹ 2.92 Cr. in FY00 on annualised basis.
Revenue:
₹ 67.66 Cr.
EBITDA Margin:
9.61
% 
Net Worth: ₹ 7.58 Cr.
Market Capitalisation:
[●]
P/E:
14.00 times
P/BV: [●]
EV/EBITDA: 1.64 times
Financial results of ANG Lifesciences India IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | FY17 | FY16 | FY15 | ||
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 46.86 | 35.49 | 25.84 | ||
| Net Worth | 7.58 | 4.76 | 3.12 | ||
| Total Debt | 11.57 | 11.76 | 10.14 | ||
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
67.66 | 54.92 | 36.84 | ||
EBITDA
EBITDA on annualised basis |
6.50 | 4.92 | 3.19 | ||
PAT
PAT on annualised basis |
2.92 | 1.65 | 0.40 | ||
ANG Lifesciences India IPO PAT Margin is 4.32 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows ANG Lifesciences India IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | FY17 | FY16 | FY15 |
|---|---|---|---|
| EBITDA Margin (%) | 9.61 | 8.96 | 8.66 |
| PAT Margin (%) | 4.32 | 3.00 | 1.09 |
| EPS (₹) | 7.93 | 4.49 | 1.10 |
| ROE (%) | 38.52 | 34.66 | 12.82 |
| ROCE (%) | [●] | [●] | [●] |
| ROA (%) | 6.23 | 4.65 | 1.55 |
| Debt to Equity | 1.53 | 2.47 | 3.25 |
The market Capitalisation of ANG Lifesciences India IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The ANG Lifesciences India IPO prospectus highlights an Return on Equity (ROE) of 38.52 % , Return on Assets (ROA) of 6.23 %, and an EBITDA Margin of 9.61 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows ANG Lifesciences India IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of ANG Lifesciences India IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The ANG Lifesciences India IPO has a Price-to-Earnings (PE) ratio of 14.00 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
ANG Lifesciences India IPO reported revenue of ₹ 67.92 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from ANG Lifesciences India IPO provide insights into sales growth, market demand, and business scalability.
ANG Lifesciences India recorded an EBITDA of ₹ 6.50 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
ANG Lifesciences India Profit After Tax (PAT) is ₹ 2.92 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 67.66 Cr.
EBITDA Margin:
9.61
%
Net Worth: ₹ 7.58 Cr.
Market Capitalisation:
[●]
P/E:
14.00 times
P/BV: [●]
EV/EBITDA:
[●]
ANG Lifesciences India operates in Pharmaceutical and Manufacturing And Marketing Of Finished Pharmaceutical Formulations In A Dosage Form Of Sterile Dry Powder Injection Vials.. The Issue is listed on BSE SME in Sep, 2017. ANG Lifesciences India IPO size was 12.01 with Issue price of 80.00 .
Merchant Banker(s) of ANG Lifesciences India IPO: Guiness Corporate Advisors Private Limited
ANG Lifesciences India IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
ANG Lifesciences India IPO listed at a listing price of 96.00 against the offer price of 80.00.
The current market price of ANG Lifesciences India is 31.13.
Why Us?
